Nisa Investment Advisors
CATX icon

Nisa Investment Advisors’s Perspective Therapeutics CATX Stock Holding History

Nisa Investment Advisors’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$477 Sell
140
-12,552
-99% -$47.4K ﹤0.01% 2952
2026
Q1 		$52.9K Buy
12,692
+12,552
+8,966% +$53K ﹤0.01% 1644
2025
Q4 		$385 Sell
140
-4,599
-97% -$13.1K ﹤0.01% 2847
2025
Q3 		$16.3K Hold
4,739
– – ﹤0.01% 2084
2025
Q2 		$16.3K Sell
4,739
-458
-9% -$1.21K ﹤0.01% 2039
2025
Q1 		$11.1K Buy
5,197
+4,397
+550% +$13.2K ﹤0.01% 2075
2024
Q4 		$2.55K Sell
800
-154
-16% -$1.26K ﹤0.01% 2416
2024
Q3 		$12.7K Buy
+954
New +$12.7K ﹤0.01% 2044

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Nisa Investment Advisors's CATX Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Perspective Therapeutics (CATX) stake by 99% in Q2 2026, selling an estimated $47.4K and leaving 140 shares worth $477. The position accounts for ﹤0.01% of the portfolio, ranked #2952.

Nisa Investment Advisors first reported a position in CATX in Q3 2024 and has held it in 8 quarters since. The position peaked at $52.9K in Q1 2026. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Nisa Investment Advisors held 140 shares of Perspective Therapeutics worth $477 as of Q2 2026.
  • Nisa Investment Advisors sold 12,552 Perspective Therapeutics shares in Q2 2026, an estimated $47.4K.
  • Perspective Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2952 holding.
  • Nisa Investment Advisors first reported a position in Perspective Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Nisa Investment Advisors's Perspective Therapeutics position peaked at $52.9K in Q1 2026.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.